Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) announces that it closed its initial public offering of 50,000,000 units at $10.00 per unit. The gross proceeds from the offering were $500 million before deducting underwriting discounts and offering expenses. The units began trading on The Nasdaq Global Market (“Nasdaq”) under the ticker symbol “DMIIU” on September 25, 2025. While the Company may pursue a business combination target in any business, industry or geographical location, it intends to focus its search for businesses in the pharmaceutical industry.
Read the full article: Drugs Made In America Acquisition II Corp. Announces Closing of $500M IPO //
Source: https://www.globenewswire.com/news-release/2025/09/26/3157247/0/en/Drugs-Made-In-America-Acquisition-II-Corp-Announces-Closing-of-500-000-000-Initial-Public-Offering.html